Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Rabie

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
The Pediatric Infectious Disease Journal|January 8, 2024
Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of AgeAdrie Bekker, Jincheng Yang, Jiajia Wang, et al.
Pediatrics|September 19, 2012
Variability of growth in children starting antiretroviral treatment in southern AfricaThomas Gsponer, Ralf Weigel, Mary-Ann Davies, et al.
AIDS (London, England)|September 10, 2020
Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern AfricaPriscilla R Tsondai, Kate Braithwaite, Geoffrey Fatti, et al.
African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|May 2, 2022
SARS-CoV-2 in children and their accompanying caregivers: Implications for testing strategies in resource limited hospitalsLiezl Smit, Andrew Redfern, Sadia Murray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012Mireille Porter, Mary-Ann Davies, Muntanga K Mapani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2014
Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort studyEliane Rohner, Fabio Valeri, Mhairi Maskew, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 2, 2021
Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE StudyAdrie Bekker, Helena Rabie, Nicolas Salvadori, et al.
The Lancet. HIV|September 10, 2019
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaborationValeriane Leroy, Karen Malateste, Helena Rabie, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsMary-Ann Davies, Margaret May, Carolyn Bolton-Moore, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
The Pediatric Infectious Disease Journal|January 8, 2024
Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of AgeAdrie Bekker, Jincheng Yang, Jiajia Wang, et al.
Pediatrics|September 19, 2012
Variability of growth in children starting antiretroviral treatment in southern AfricaThomas Gsponer, Ralf Weigel, Mary-Ann Davies, et al.
AIDS (London, England)|September 10, 2020
Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern AfricaPriscilla R Tsondai, Kate Braithwaite, Geoffrey Fatti, et al.
African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|May 2, 2022
SARS-CoV-2 in children and their accompanying caregivers: Implications for testing strategies in resource limited hospitalsLiezl Smit, Andrew Redfern, Sadia Murray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012Mireille Porter, Mary-Ann Davies, Muntanga K Mapani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2014
Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort studyEliane Rohner, Fabio Valeri, Mhairi Maskew, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 2, 2021
Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE StudyAdrie Bekker, Helena Rabie, Nicolas Salvadori, et al.
The Lancet. HIV|September 10, 2019
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaborationValeriane Leroy, Karen Malateste, Helena Rabie, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsMary-Ann Davies, Margaret May, Carolyn Bolton-Moore, et al.
Pageof 15